IMMU-90. Assessing immune cell infiltration into distinct regions of the dura in preclinical glioblastoma models

IMMU-90。评估临床前胶质母细胞瘤模型中免疫细胞向硬脑膜不同区域的浸润

阅读:1

Abstract

Glioblastoma (GBM) is a highly aggressive and the most common primary malignant tumor of the central nervous system (CNS) in adults. Several obstacles to developing immunotherapies for GBM include an incomplete understanding of CNS-specific antigen presentation and T cell priming. Recent literature has suggested the dura as an important site for immune activation in preclinical models. However, the exact anatomic locations within the dura, especially in glioma-bearing mice, remain unclear. To better understand this process, we sought to characterize the immune cell composition and accumulation of tumor-associated materials within different regions of the dura. Specifically, we dissected the dura from tumor- or PBS-injected mice into anatomically distinct regions including the superior sagittal sinus (SSS), transverse sinus (TS), dural-associated lymphoid tissue (DALT), and non-sinus regions (NS). Through flow cytometry, we observed heterogeneity in immune cell infiltration into these different dural sites from glioma-bearing mice compared to that of PBS injected controls. Most importantly, CD3(+) T cells increased throughout the dura in response to tumor injection, with preferential infiltration into the DALT, SSS, and NS regions (>2 fold compared to PBS) compared to the TS region (~1.2 fold). CD8(+) and CD4(+) T cells, as well as cDC2 cells, followed similar infiltration trends. Conversely, cDC1 had the highest infiltration into the TS and NS regions (~28 fold) compared to the DALT and SSS regions (~15, ~20 fold, respectively). In addition, we employed a fluorescently labeled tumor cell line to track immune-mediated transportation of tumor materials. Through both flow cytometry and confocal imaging of the dura, we detected the presence of immune cells with tumor-derived fluorophore in various regions of the dura. Thus, these findings suggest that the dura, especially the DALT, is an important site of immune activation and leveraging this unique tissue site may offer new opportunities for GBM immunotherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。